31 results match your criteria: "Hôpitaux Universitaires Strasbourg[Affiliation]"

Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease.

Clin Immunol

July 2024

Translational Medicine, Servier, Research and Development, Gif-Sur-Yvette, France; Centre de Recherche sur l'Inflammation, INSERM UMRS1149, Paris, France. Electronic address:

Article Synopsis
  • Primary Sjögren disease (pSD) is an autoimmune disease that causes dryness in the body and is not yet treatable effectively.
  • Researchers studied blood samples from pSD patients to find groups of genes (called Consensus gene Modules) that reveal important information about the disease.
  • They discovered that different gene groups could predict how well patients respond to certain treatments, which could help doctors find better ways to help people with pSD in the future.
View Article and Find Full Text PDF

Phospholipase A/acyltransferase 3 (PLAAT3) is a phospholipid-modifying enzyme predominantly expressed in neural and white adipose tissue (WAT). It is a potential drug target for metabolic syndrome, as Plaat3 deficiency in mice protects against diet-induced obesity. We identified seven patients from four unrelated consanguineous families, with homozygous loss-of-function variants in PLAAT3, who presented with a lipodystrophy syndrome with loss of fat varying from partial to generalized and associated with metabolic complications, as well as variable neurological features including demyelinating neuropathy and intellectual disability.

View Article and Find Full Text PDF

Diagnosis and classification of optic neuritis.

Lancet Neurol

December 2022

Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Faculty of Brain Sciences, London, UK.

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease.

View Article and Find Full Text PDF

Objective: To develop and validate a patient knowledge questionnaire regarding axial spondyloarthritis (axSpA).

Methods: Knowledge considered essential for patients with axSpA was identified through Delphi rounds among rheumatologists, healthcare professionals (HCPs), and patients, then reformulated to develop the knowledge questionnaire. Cross-sectional validation was performed in 14 rheumatology departments to assess internal validity (Kuder-Richardson coefficient), external validity, acceptability, reproducibility (Lin concordance correlation coefficient), and sensitivity to change (knowledge score before vs after patient education sessions and effect size).

View Article and Find Full Text PDF

Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS).

Joint Bone Spine

July 2021

Inserm 1227, LabEx IGO, rhumatologie, centre de référence maladies rares CERAINO, université de Bretagne Occidentale, CHU de Brest, 29200 Brest, France. Electronic address:

Article Synopsis
  • - The study aimed to analyze how common and important skin disorders are in patients with primary Sjögren syndrome (pSS) using data from two different French cohorts and a clinical trial on treatment effectiveness.
  • - Results showed that skin issues, particularly those recorded in the disease activity index (ESSDAI), were uncommon but linked to other disease activities like neurological and muscular problems. In patients who had skin assessments, there was a higher rate of dermatological issues compared to those who didn't.
  • - The findings emphasized that while specific skin manifestations are rare, skin dryness is quite prevalent and correlates with increased pain and dryness scores in patients, highlighting the need for dermatological evaluations.
View Article and Find Full Text PDF
Article Synopsis
  • * A study of 202 alloHCT patients revealed that 35% had veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a significant cause of MOF, with 69% of these cases previously undiagnosed.
  • * Factors such as prior liver issues and disease status were linked to the likelihood of developing VOD/SOS, and the findings point to the need for updated criteria to better identify and manage late-onset cases occurring more
View Article and Find Full Text PDF

Allogeneic hematopoietic cell transplantation (HCT) is recommended in high-risk patients with T cell acute lymphoblastic leukemia (T-ALL). For patients without an HLA-identical donor, haploidentical (haplo-) HCT is becoming the leading source of stem cell donation. However, data are scarce on predictive factors for outcome in that setting.

View Article and Find Full Text PDF

BACKGROUNDChronic hepatitis C virus (HCV) infection is characterized by a severe impairment of HCV-specific CD4+ T cell help that is driven by chronic antigen stimulation. We aimed to study the fate of HCV-specific CD4+ T cells after virus elimination.METHODSHCV-specific CD4+ T cell responses were longitudinally analyzed using MHC class II tetramer technology, multicolor flow cytometry, and RNA sequencing in a cohort of patients chronically infected with HCV undergoing therapy with direct-acting antivirals.

View Article and Find Full Text PDF

Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort.

J Clin Virol

November 2019

Laboratoire de Virologie, Hôpital Brabois, CHRU de Nancy, Vandoeuvre-les-Nancy, France; LCPME (Laboratoire de Chimie Physique et Microbiologie pour les Matériaux et l'Environnement), UMR 7564, Faculté de Pharmacie, Nancy, F-54000, France. Electronic address:

Background: "Treatment as Prevention" (TasP) aims to reduce new HIV infections through higher enrolment on suppressive antiretroviral therapy (ART).

Objectives: We studied the current epidemic and possible impact of TasP in a French HIV cohort including MSM and migrant subjects.

Study Design: Socio-demographic, clinical and laboratory variables were collected during the follow-up of 6995 HIV-infected patients.

View Article and Find Full Text PDF

Purpose: The outcome of desmoid-type fibromatosis (DTF) is unpredictable. Currently, a wait-and-see approach tends to replace large en bloc resection as the first therapeutic approach. Nevertheless, there are no validated factors to guide the treatment choice.

View Article and Find Full Text PDF
Article Synopsis
  • Cytomegalovirus (CMV) infection is prevalent among individuals with HIV, and its effects on CD4+ and CD8+ T cells following cART (combination antiretroviral therapy) initiation are not fully understood.
  • A study from the French Dat'AIDS cohort included 503 patients who achieved HIV suppression, finding that 88.3% were CMV seropositive (CMV+), which correlated negatively with the CD4:CD8 T cell ratio.
  • The research suggests that CMV+ status may hinder normal T cell ratios, hinting at faster T cell aging, which calls for closer monitoring and evaluation of the potential benefits of treating asymptomatic CMV co-infections in HIV patients.
View Article and Find Full Text PDF

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.

Medicine (Baltimore)

October 2016

Aix-Marseille University, APHM Hôpital Sainte-Marguerite, Immuno-Hematology Clinic Inserm U912 (SESSTIM), Marseille CHU Hotel Dieu, Infectious Diseases Unit, Nantes Inserm Université de Toulouse III, UMR1027, Toulouse APHP- Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectious Diseases Center, IHU Imagine Pasteur Institut, Medical Care Center, Necker-Pasteur Infectious Diseases Center France Université Paris Descartes, Sorbonne Paris Cité, Paris Infectious Diseases Department, CHU of Nice, University Nice Sophia-Antipolis Hôpitaux Universitaires Strasbourg, Center for HIV care, Strasbourg Hospital Tourcoing, Infectious Disease Unit, Tourcoing INSERM, UMR 1027, Toulouse III University, Toulouse, F-31000, France; CHU Toulouse, COREVIH Toulouse, F-31000 AP-HP, Hospital Pitie-Salpetriere, Department of Infectious Diseases UPMC Univ Paris UMRS 943, Paris CHU de Fort de France, Service de maladies infectieuses et tropicales, Martinique Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, EA 4537; Centre Hospitalier Universitaire de Pointe-à-Pitre, Inserm CIC1424, Service de Maladies Infectieuses et Tropicales, Dermatologie, Médecine Interne, Pointe-à-Pitre, France.

The aim of the study was to investigate the impact of first-line combined antiretroviral therapy (cART) regimen on the course of CD8 T-cell counts in human immunodeficiency virus (HIV)-infected patients.A retrospective observational study conducted on the French DAT'AIDS Cohort of HIV-infected patients.We selected 605 patients initiating a first-line cART between 2002 and 2009, and which achieved a sustained undetectable HIV plasma viral load (pVL) for at least 12 months without cART modification.

View Article and Find Full Text PDF

[Persistant Legionella pneumophila and Enterococcus faecium pulmonary infection: Look for an abscess!].

Presse Med

April 2016

Université de Strasbourg, faculté de médecine de Strasbourg, hôpitaux universitaires de strasbourg et FMTS, hôpital de Hautepierre, service de réanimation médicale, 1, avenue Molière, 67098 Strasbourg cedex, France.

View Article and Find Full Text PDF

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.

Lancet Infect Dis

November 2015

Institut National de la Santé et de la Recherche Médicale, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Sorbonne Universités, UPMC Université Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Département de santé publique, Groupe Hospitalier Est Parisien, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Background: Revaccination with double-dose hepatitis B vaccine has been recommended in HIV-infected patients who do not respond to standard vaccination, but has not yet been assessed. We aimed to compare the safety and immunogenicity of a reinforced hepatitis B revaccination protocol with the standard revaccination schedule in HIV-infected patients not responding to primary vaccination.

Methods: We did this multicentre, open-label, randomised controlled trial, at 53 centres in France.

View Article and Find Full Text PDF

Aim: The French Sarcoma Group performed this retrospective analysis of the 'RetrospectYon' database with data of patients with recurrent advanced soft tissue sarcoma (STS) treated with trabectedin 1.5 mg/m(2) as a 24-h infusion every three weeks.

Methods: Patients who achieved non-progressive disease after six initial cycles could receive long-term trabectedin treatment until disease progression.

View Article and Find Full Text PDF

Background: The prevalence of osteopenia and osteoporosis is increased in human immunodeficiency virus (HIV)-infected patients. The pathogenesis of this low bone mineral density (BMD) is multifactorial.

Methods: We conducted a prospective study over a 2-year period of the BMD in non-treated ARV-naïve HIV-infected-males, in comparison to HIV-infected males commencing a first ARV treatment, and analyzed the evolution of bone turnover markers.

View Article and Find Full Text PDF

Background: The present study evaluated immunogenicity and tolerance of two-dose influenza A/H1N1pdm09 vaccination in allogeneic hematopoietic stem cell transplantation (HSCT) recipients, and compared the vaccine-induced humoral response to that triggered by natural infection in another group of HSCT patients.

Methods: Adult allogeneic HSCT recipients vaccinated with two doses of influenza A/H1N1pdm09 vaccine, separated by 3 weeks, and patients with proven influenza A/H1N1pdm09 infection were included. Antibody responses were measured by hemagglutination-inhibition assay 1) on days 0, 21, 42 and 6 months after the first vaccine injection in vaccinated patients and 2) before pandemic and after influenza A/H1N1pdm09 infection, in patients presented natural infection.

View Article and Find Full Text PDF

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.

Eur Respir J

February 2009

Dept of Chest Diseases, Hôpitaux Universitaires Strasbourg, 1 place de l'Hôpital, BP 426, 67091 Strasbourg, France.

The epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) erlotinib improves survival of lung cancer as second- or third-line therapy. However, after an initial response, most patients will recur, particularly within the central nervous system. The present study reports the case of a 27-yr-old nonsmoking male presenting with a metastatic lung adenocarcinoma with EGFR exon 19 deletion, associated with sensitivity to EGFR-TKI.

View Article and Find Full Text PDF

The disconnectivity hypothesis proposes that schizophrenia results from poor or miswired anatomical connections. Theoretically, its functional counterpart should be disintegration. Integration is thought to allow segregated neurons to interact as a coherent whole, referred to as the "core", while the non-interacting part of the brain is referred to as the "rest".

View Article and Find Full Text PDF

A combination of 2 nucleoside analogues and 1 protease inhibitor is usually recommended in postexposure prophylaxis. Because of the complex treatment schedule and frequent adverse effects, however, this regimen is often not completed. Therefore, since January 2000, we have used nevirapine (NVP), 200 mg/d, for only 4 days in combination with 2 nucleoside analogues for 1 month to improve adherence and completion rates.

View Article and Find Full Text PDF

Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.

Growth Horm IGF Res

June 2004

Institut de Génétique et Biologie Moléculaire et Cellulaire, INSERM/CNRS/Université Louis Pasteur, Faculté de Médecine and Hôpitaux Universitaires Strasbourg, Illkirch-Cedex, Strasbourg 67404, France.

The Fragile X (FRAXA) syndrome is the most common cause of familial (monogenic) mental retardation and is widespread in human populations. This syndrome is characterised by an unusual mode of transmission for an X-linked disease. In affected families, one frequently finds clinically normal transmitting males, whose daughters - also clinically normal - have a high risk of having affected children.

View Article and Find Full Text PDF

We describe an easily recognizable and previously not individualized clinical syndrome that can reveal solitary plasmacytoma of bone. We report 4 patients with a slowly extending violaceous skin patch overlying a solitary plasmacytoma of bone, associated with enlarged regional lymph nodes. Biopsies of the cutaneous lesion and the lymph nodes were not specific, although increased dermal mucin deposition and vascular proliferation were present in all skin specimens.

View Article and Find Full Text PDF

Some microorganisms transmitted to man via tick bite are responsible for infections, which can be associated with neuro-meningeal complications. TBE virus is the most frequent virus associated with potentially severe neurological lesions. No treatment is available so far.

View Article and Find Full Text PDF